Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains

Journal of Pharmaceutical Sciences

Volumn 91, Issue 2, 2002, Pages 396-404

  Jaafari, M R ^a   Foldvari, M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

ICAM 1; Liposome targeting; Melanoma; Peptide

Indexed keywords

ANTINEOPLASTIC AGENT; INTERCELLULAR ADHESION MOLECULE 1; LIPOSOME;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; MELANOMA; PROTEIN EXPRESSION; TARGET CELL;

EID: 0036167827     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10062     Document Type: Article

References (37)

1. Drug delivery and targeting
2. Immunoliposomes for cancer treatment
3. Studies on carbohydrate-binding proteins using liposome-based systems - I. Preparation of neoglycoprotein-conjugated liposomes and the feasibility of their use as drug-targeting devices
4. Targeting of liposomes to HIV-1-infected cells by peptides derived from the CD4 receptor
5. A novel peptide-grafted liposomal delivery system targeted to macrophages
6. 0 protein: The major glycoprotein of peripheral nerve myelin
7. 0 protein: Homology to immunoglobulin superfamily
8. Isolation and analysis of the gene encoding peripheral myelin protein zero
9. 0 protein: Evidence for early expression in avians
10. Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin
11. 0 glycoprotein from peripheral nerve myelin into human M21 melanoma cells
12. 0 glycoprotein from avian peripheral nerve myelin
13. 0 protein as a model
14. 0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression
15. 0-protein as a homophilic adhesion molecule
16. Protein zero of peripheral nerve myelin: Biosynthesis, membrane insertion, and evidence for homotypic interaction
17. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1)
18. Targeting of liposomes to human epidermal keratinocytes through adhesive peptides from immunoglobulin domains in the presence of IFN-γ
19. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias in lymphoproliferative disorders
20. Protein immobilization on the surface of liposomes via carbodiimmide activation in the presence of N-hydroxysulfosuccinimide
21. The novel carbohydrate epitope L3 is shared by some neural cell adhesion molecules
22. 0 protein inhibits homophilic cell adhesion, competition assay with transformants and peptides
23. The immunoglobulin superfamily - Domains for cell surface recognition
24. 0, the major structural protein of peripheral nerve myelin
25. A novel LFA-1 activation epitope maps to the I domain
26. Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3
27. The sticking point: How integrins bind to their ligands
28. I domain of beta 2 integrin lymphocyte function-associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1
29. Induction by IL 1 and interferon-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)
30. Adhesion receptors of the immune system
31. Therapeutic aspects of ICAM-1 regulation in the skin
32. De novo expression of intercellular adhesion molecule-1 in melanoma correlates with increased risk of metastasis
33. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions
34. Clinical significance of αVβ3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions
35. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma
36. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells
37. Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG)